Li, Xiaojun
Lan, Qiusheng
Lai, Wei
Wu, Heng
Xu, Heyang
Fang, Kai
Chu, Zhonghua
Zeng, Yujie
Funding for this research was provided by:
National Natural Science Foundation of China (81871981, 81702902)
Natural Science Foundation of Guangdong Province (2019A1515010646)
Chinese Society of Clinical Oncology (Y-SY201901-0079)
Article History
Received: 2 April 2022
Accepted: 21 July 2022
First Online: 27 August 2022
Declarations
:
: All patients gave their informed consent prior to their inclusion in the study. Prior to the usage of the human tissue samples for research purposes, ethical approval was attained from the Ethics Committee of Sun Yat-sen Memorial Hospital and all experiments were carried out in accordance with declaration of Helsinki. The cell lines used in this study did not require ethics approval.
: Figure was permitted to be sublicensed for use in journal publications by BioRender (agreement number BN23R49LHK).
: The authors declare that they have no conflicts of interest.